Overview
- UnitedHealth said roughly 78% of its Medicare Advantage members are preliminarily in plans rated 4 stars or higher, based on early CMS evaluations, with official ratings due in October.
- The disclosure sent shares up about 9% on Tuesday, extending a multiweek rally in the stock.
- Management plans to reiterate 2025 adjusted EPS guidance of at least $16 and noted the Amedisys acquisition will be dilutive next year without changing that target.
- Four-star and higher ratings qualify plans for quality bonus payments that meaningfully affect Medicare Advantage revenue and margins.
- UnitedHealthcare is pruning unprofitable Medicare Advantage offerings and expects to lose about 600,000 enrollees from plan exits as it works to restore profitability.